BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26260959)

  • 1. Benign thyroid nodules with RAS mutation grow faster.
    Puzziello A; Guerra A; Murino A; Izzo G; Carrano M; Angrisani E; Zeppa P; Marotta V; Faggiano A; Vitale M
    Clin Endocrinol (Oxf); 2016 May; 84(5):736-40. PubMed ID: 26260959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of RAS mutation by pyrosequencing in thyroid cytology samples.
    Guerra A; Carrano M; Angrisani E; Puzziello A; Izzo G; Di Crescenzo V; Vatrella A; Vitale M
    Int J Surg; 2014; 12 Suppl 1():S91-4. PubMed ID: 24866065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
    Radkay LA; Chiosea SI; Seethala RR; Hodak SP; LeBeau SO; Yip L; McCoy KL; Carty SE; Schoedel KE; Nikiforova MN; Nikiforov YE; Ohori NP
    Cancer Cytopathol; 2014 Dec; 122(12):873-82. PubMed ID: 25132659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
    Medici M; Kwong N; Angell TE; Marqusee E; Kim MI; Frates MC; Benson CB; Cibas ES; Barletta JA; Krane JF; Ruan DT; Cho NL; Gawande AA; Moore FD; Alexander EK
    BMC Med; 2015 Aug; 13():184. PubMed ID: 26253102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.
    Clinkscales W; Ong A; Nguyen S; Harruff EE; Gillespie MB
    Otolaryngol Head Neck Surg; 2017 Mar; 156(3):472-479. PubMed ID: 28116986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance.
    Jang EK; Kim WG; Kim EY; Kwon H; Choi YM; Jeon MJ; Baek JH; Lee JH; Kim TY; Shong YK; Choi J; Song DE; Kim WB
    Endocrine; 2016 May; 52(2):305-12. PubMed ID: 26547216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears.
    Rehfeld C; Münz S; Krogdahl A; Jensen EM; Siebolts U; Ferraz C; Bösenberg E; Hegedüs L; Paschke R; Eszlinger M
    Horm Metab Res; 2013 Jul; 45(7):513-7. PubMed ID: 23508716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative detection of RAS mutation may guide extent of thyroidectomy.
    Patel SG; Carty SE; McCoy KL; Ohori NP; LeBeau SO; Seethala RR; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2017 Jan; 161(1):168-175. PubMed ID: 27863786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High growth rate of benign thyroid nodules bearing RET/PTC rearrangements.
    Sapio MR; Guerra A; Marotta V; Campanile E; Formisano R; Deandrea M; Motta M; Limone PP; Fenzi G; Rossi G; Vitale M
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E916-9. PubMed ID: 21411555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency assessment of BRAF mutation, KRas mutation, and RASSF1A methylation in nodular goitre based on fine-needle aspiration cytology specimens Ocena częstości występowania mutacji genów BRAF, KRas oraz.
    Koziołek M; Bińczak-Kuleta A; Stepaniuk M; Parczewski M; Andrysiak-Mamos E; Sieradzka A; Safranow K; Osowicz-Korolonek L; Kiedrowicz B; Kram A; Ciechanowicz A; Syrenicz A
    Endokrynol Pol; 2015; 66(5):384-93. PubMed ID: 26457492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules.
    Stence AA; Gailey MP; Robinson RA; Jensen CS; Ma D
    Yale J Biol Med; 2015 Dec; 88(4):351-8. PubMed ID: 26604858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
    Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
    Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow-Up.
    Angell TE; Frates MC; Medici M; Liu X; Kwong N; Cibas ES; Kim MI; Marqusee E
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1477-83. PubMed ID: 26353010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma.
    Howitt BE; Jia Y; Sholl LM; Barletta JA
    Thyroid; 2013 Oct; 23(10):1256-62. PubMed ID: 23477374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
    Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY
    Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS-positive thyroid nodules.
    Angell TE
    Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):372-376. PubMed ID: 28639967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.